Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: a retrospective multicenter study.

Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: a retrospective multicenter study.

Item
http://www.wikidata.org/entity/Q33405470
Better transplant outcome with pre-transplant marrow response after hypomethylating treatment in higher-risk MDS with excess blasts.The role of hypomethylating agents in myelodysplastic syndrome: changing the management paradigm.Toward resolving the unsettled role of iron chelation therapy in myelodysplastic syndromes.The clinical use of DNA methyltransferase inhibitors in myelodysplastic syndromes.Invasive fungal infections: managing the continuum of risk in HCT patients.A retrospective study evaluating the impact of infectious complications during azacitidine treatment.The risk of infections in patients with myelodysplastic syndromes in 2016.Infectious complications in patients with myelodysplastic syndromes: A review of the literature with emphasis on patients treated with 5-azacitidine.Incidence, etiology and timing of infections following azacitidine therapy for myelodysplastic syndromes.The impact of antimicrobial prophylaxis in morbidity and infections during azacitidine treatment.Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia.Infections associated with bendamustine containing regimens in hematological patients: a retrospective multi-center study.Effects of 5-azacytidine on natural killer cell activating receptor expression in patients with refractory anemia with excess of blasts.A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ⩽30% blasts.Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).Necrotizing fasciitis in two patients with myelodysplastic syndrome treated with azacitidine.Hypoalbuminemia and hypergammaglobulinemia are associated with an increased infection risk in patients with myeloid malignancies treated with azacitidine. A 3-year monocentric retrospective study.
P2860

Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: a retrospective multicenter study.

Item
http://www.wikidata.org/entity/Q33405470
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Predicting infections in high- ...... trospective multicenter study.
@ast
Predicting infections in high- ...... trospective multicenter study.
@en
type
label
Predicting infections in high- ...... trospective multicenter study.
@ast
Predicting infections in high- ...... trospective multicenter study.
@en
prefLabel
Predicting infections in high- ...... trospective multicenter study.
@ast
Predicting infections in high- ...... trospective multicenter study.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Predicting infections in high- ...... trospective multicenter study.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921